High expression of ARPC1B correlates with immune infiltration and poor outcomes in glioblastoma DOI Creative Commons
Chuangxin Liao, Wenli Chen,

Guixin Xu

et al.

Biochemistry and Biophysics Reports, Journal Year: 2023, Volume and Issue: 37, P. 101619 - 101619

Published: Dec. 19, 2023

To investigate the role of ARPC1B in GBM and its prognostic value.

Language: Английский

IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma DOI Open Access
Kyle D. Klingbeil, Jack Pengfei Tang, Danielle S. Graham

et al.

Cancers, Journal Year: 2023, Volume and Issue: 15(18), P. 4489 - 4489

Published: Sept. 9, 2023

Background: Although IGF2BP3 has been implicated in tumorigenesis and poor outcomes multiple cancers, its role soft-tissue sarcoma (STS) remains unknown. Preliminary data have suggested an association with expression among patients well-differentiated/dedifferentiated liposarcoma (WD/DD LPS), a disease where molecular risk stratification is lacking. Methods: We examined the survival associations of via univariate multivariate Cox regression three unique datasets: (1) Cancer Genome Atlas (TCGA), (2) in-house gene microarray, (3) tissue microarray (TMA). A fourth dataset, representing independent TMA, was used for validation. Results: Within TCGA prognostic factor uniquely DD LPS (OS 1.6 vs. 5.0 years, p = 0.009). WD/DD associated worse 7.7 21.5 0.02). protein also portended 3.7 13.8 < 0.001), which confirmed our validation cohort 2.7 14.9 0.001). In model, OS, (HR 2.55, 0.034). Conclusion: highly expressed subset LPS. Across datasets, biomarker progression survival.

Language: Английский

Citations

3

Deciphering the Divergent Gene Expression Landscapes of m6A/m5C/m1A Methylation Regulators in Hepatocellular Carcinoma Through Single-Cell and Bulk RNA Transcriptomic Analysis DOI Creative Commons

Hang-Tsung Liu,

Cheng‐Shyuan Rau,

Yueh‐Wei Liu

et al.

Journal of Hepatocellular Carcinoma, Journal Year: 2023, Volume and Issue: Volume 10, P. 2383 - 2395

Published: Dec. 1, 2023

Introduction: RNA modifications mediated by the m6A, m1A, and m5C regulatory genes are crucial for progression of malignancy.This study aimed to explore expression regulator m6A/m5C/m1A methylation at single-cell level validate their in cancerous adjacent para-cancerous liver tissues adult patients with HCC who underwent tumor resection.Methods: The bulk sequencing from Cancer Genome Atlas (TCGA) database (scRNA-seq) data obtained Gene Expression Omnibus (GEO) were used identify dysregulated hepatocellular carcinoma (HCC).A real-time polymerase chain reaction (real-time PCR) was measure collected human compared tissues.Immune cell infiltration these significantly expressed methylation-related evaluated using Timer2.0.Results: A discrepancy gene observed between scRNA-seq.The clustered heatmap scRNA-seq-identified TCGA cohort revealed heterogeneous regulators within cancer, whereas more homogeneous.The PCR validated significant overexpression DNMT1, NSUN5, TRMT6, IGF2BP1, IGFBP3, which identified scRNA-seq, IGFBP2, sequencing.These mainly correlated natural killer cells.Discussion: This suggests that cellular diversity inside tumors contributes traditional scRNA-seq.This five will be focus further studies regarding function HCC.

Language: Английский

Citations

3

The relationship between polymorphism of IGF2BP2 gene rs4402960 and risk of pan-cancer: a meta-analysis and a bioinformatics analysis DOI
Fengke Lu,

G.F. Gao,

Hongyu Zhang

et al.

Nucleosides Nucleotides & Nucleic Acids, Journal Year: 2024, Volume and Issue: unknown, P. 1 - 17

Published: March 31, 2024

Objective To conduct a meta-analysis and bioinformatics analysis to assess the relationship between IGF2BP2 gene polymorphism pan-cancer risk.

Language: Английский

Citations

0

The relationship between polymorphism of IGF2BP2 gene rs4402960 and risk of pan-cancer: a meta-analysis and a bioinformatics analysis DOI Creative Commons
Fengke Lu, Hongyu Zhang, Wei Zhang

et al.

Research Square (Research Square), Journal Year: 2023, Volume and Issue: unknown

Published: July 18, 2023

Abstract Background Although some studies have established the relationship between insulin-like growth factor 2 mRNA-binding protein (IGF2BP2) rs4402960 polymorphism and pathogenesis of cancer. But results are contradictory. We conducted a meta-analysis to assess IGF2BP2 gene cancer risk. Furthermore, expression in pan-cancer tissues normal was further analyzed from perspective bioinformatics analysis. Methods Using published case–control up August 15, 2021, literature search included searches PubMed, Web Science, EMBASE determine samples that met inclusion criteria. The heterogeneity test used five genetic models. Odds ratios (OR), 95% confidence intervals (CI), p-values were evaluate combined effects various Sensitivity analysis publication bias also performed. Transcriptomic information on corresponding clinical downloaded TCGA GTEx databases. Differences kinds analysed. Results This contained 6 studies, with 5,908 cases 7,890 controls. There only an association risk heterozygous model (heterozygous: OR = 1.080, CI 1.003–1.163, p 0.041). sensitivity examined effect research by deleting one study turns. No found over-expressed breast cancer, non-small cell lung colorectal esophageal (P < 0.001). Conclusions showed may be related Breastcancer, Non-small Cell Lung Cancer, Colorectal Breast tissues. as index early screening prognosis treatment.

Language: Английский

Citations

0

High expression of ARPC1B correlates with immune infiltration and poor outcomes in glioblastoma DOI Creative Commons
Chuangxin Liao, Wenli Chen,

Guixin Xu

et al.

Biochemistry and Biophysics Reports, Journal Year: 2023, Volume and Issue: 37, P. 101619 - 101619

Published: Dec. 19, 2023

To investigate the role of ARPC1B in GBM and its prognostic value.

Language: Английский

Citations

0